NCT07282080 Discover Better Body Composition With Green Light!
| NCT ID | NCT07282080 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Efforia, Inc |
| Condition | Body Composition |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-08-15 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-08-15 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigation into Green Light Therapy study using EmeraldLED for 15-minute sessions, twice a week, to support positive changes in body composition.
Eligibility Criteria
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: -individuals with eye conditions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07282080 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Body Composition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07282080 currently recruiting?
Yes, NCT07282080 is actively recruiting participants. Contact the research team at help@efforia.com for enrollment information.
Where is the NCT07282080 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07282080 clinical trial?
NCT07282080 is sponsored by Efforia, Inc. The trial plans to enroll 100 participants.